Vetera VEWT + WNV Equine Vaccine

$35.75$291.60

Vetera VEWT + WNV Equine Vaccine is for the prevention of Eastern, Western and Venezuelan Equine Encephalomyelitis, Tetanus, and Viremia due to West Nile Virus.

Clear
SKU: N/A Categories: , Tag: Overnight Shipping Required

Description

Vetera VEWT + WNV Equine Vaccine is a 3 way Encephalomyelitis, West Nile Virus Vaccine-Tetanus Toxoid. Eastern and Western and Venezuelan, Killed Virus. For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity against West Nile Virus is at least 12 months. Made by Boehringer Ingelheim.

Additional information

Weight N/A
Dimensions N/A
Size

Single dose 1 ml syringe, 10 dose 10 ml vial

More Details

Indications: For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity against West Nile Virus is at least 12 months.

Formulations

Available in single dose 1 ml syringes and in 10 dose 10 ml vials.

Administration

Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

Precautions

Precautions: Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Manufacturer Product Information

BOEHRINGER INGELHEIM VETMEDICA, INC.
3239 SATELLITE BLVD., DULUTH, GA, 30096
Telephone: 800-325-9167
Fax: 816-236-2717
Website: www.bevaccinesmart.com
Website: www.bi-vetmedica.com
Website: www.haveweseenyourcatlately.com
Website: www.metacam.com
Website: www.mycathasdiabetes.com
Website: www.prrsresearch.com
Website: www.prozinc.us
Website: www.vetera-vaccines.com
Website: www.vetmedin-us.com
Website: www.yourdogsheart.com
Email: info@productionvalues.us

Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the USA product label or package insert.

Vetera® VEWT + WNV

Boehringer Ingelheim

Encephalomyelitis-West Nile Virus Vaccine

Eastern & Western & Venezuelan, Killed Virus

Tetanus Toxoid

Indications: For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus. The duration of immunity against West Nile Virus is at least 12 months.

Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.

Precautions: Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Preservatives: Gentamicin and Amphotericin B.

For Veterinary Use Only

Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.

© 2015 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

US Vet. Lic. No. 124

US Patent No. 8821889.

1 Dose/1 mL

135505-01

10 Doses/10 mL

135504-03

CPN: 1028292.1

Reviews

There are no reviews yet.

Be the first to review “Vetera VEWT + WNV Equine Vaccine”

You may also like…